BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16612144)

  • 21. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 as prognostic factor in head and neck squamous cell carcinoma.
    Lo Muzio L; Falaschini S; Farina A; Rubini C; Pezzetti F; Campisi G; De Rosa G; Capogreco M; Carinci F
    Oncol Res; 2005; 15(5):249-55. PubMed ID: 16261844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
    J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
    Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
    Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
    Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
    Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
    Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
    Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.
    Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T
    Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.
    Sen S; Carnelio S
    Histopathology; 2016 May; 68(6):897-904. PubMed ID: 26401964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
    Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
    Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
    Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
    Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
    de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
    Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous cell carcinoma.
    Xia X; Du R; Zhao L; Sun W; Wang X
    Hum Pathol; 2014 Apr; 45(4):858-65. PubMed ID: 24656097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
    Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
    Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations.
    Safi AF; Nickenig HJ; Rothamel D; Zirk M; Thiele O; Grandoch A; Scheer M; Zinser M; Zöller J; Drebber U; Kreppel M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1899-905. PubMed ID: 26447027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
    Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
    J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.